Wenzhou Medical University researchers have reimagined the spleen as a viable site for islet transplantation, enabling long-term diabetes control without the burden of full immunosuppression.

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell ...

A preclinical trial shows islet transplantation can reverse diabetes, offering hope for future treatments and improved patient outcomes.

Discover upcoming breakthroughs in Type 1 Diabetes & B-cell disorder treatments, market growth to $24B by 2031, and key trials expected by 2025-2026.

A novel islet cell therapy delivered through a single infusion lowered HbA1c and eliminated severe hypoglycemia events for all adults with type 1 diabetes who received a full dose, according to ...

Transplanting insulin-producing cells along with engineered blood-vessel-forming cells has successfully reversed type 1 diabetes in a new preclinical study. With further testing, the novel ...

Sana's first-in-human study shows HIP technology allows islet cells to avoid immune rejection and produce insulin without immunosuppression. Reliance on initial results: The press release heavily ...

For Dr. Daniel Gilada, a husband, physician and soon-to-be father of four, living with Type 1 diabetes had become “overwhelming.” “I felt so bad that it was becoming my new norm,” said ...

A groundbreaking stem cell therapy offers new hope for type 1 diabetes, ... new approach is an innovative process that transforms a patient’s own fat cells into insulin-producing islet cells.

In type 1 diabetes, the immune system destroys native beta cells, the insulin-producing cells housed within pancreatic clusters called islets of Langerhans. Islet transplantation transfers these ...